CV

CAPSOVISION INC

CV·140935107·US·Common Stock·Healthcare - Medical Devices-13D/G

CV (CAPSOVISION INC) is held by 39 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($14.4M), VANGUARD CAPITAL MANAGEMENT LLC ($8M), GEODE CAPITAL MANAGEMENT, LLC ($4.4M). Net institutional sentiment: Bullish.

39
Holders
(1 Elite)
$38.3M
Total Value
79% (39)
Consensus
31 buying - 8 selling
13F: Insider & Congress: Updated regularly
CV

Smart Money Verdict

View all
Loading verdict
Held by 39 funds
1 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Jul 1, 2026 · Activists May 6, 2026 · Congress none

InsiderICImperial Joanne CarolSell $9KJun 8, 2026
ActivistEHEliyahou Harari10.2%May 6, 2026
InsiderAPAtkinson Douglas PatrickExercise 35K shMay 5, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
1.9M(+45.4%)$14.4M0.0%-13.72%
38
Increased
1.1M(+3.1%)$8M0.0%+7.81%
28
Increased
578,482(+32.9%)$4.4M0.0%-6.24%
34
Increased
410,241(+60.2%)$3.1M0.0%-20.06%
38
Increased
240,425(+46.3%)$1.8M0.0%-3.67%
35
Increased
220,095(+44.5%)$1.7M0.0%-2.02%
35
Increased
103,630(+16.9%)$785,5150.0%+2.91%
29
Increased
79,360(+29.3%)$601,5490.0%+2.14%
31
Increased
75,021(+52.2%)$568,6570.0%-4.62%
34
Increased
46,011(+39.0%)$348,7630.0%-2.37%
31
Increased
34,700(+37.2%)$263,0260.0%-14.74%
30
Decreased
31,845(-52.7%)$241,3850.0%+9.19%
0
Increased
31,820(+210.6%)$241,1960.0%-20.46%
25
Increased
25,469(+14.5%)$193,0550.0%-0.02%
18
Increased
21,969(+67.3%)$166,5200.0%-4.77%
33
Increased
21,114(+26.4%)$160,0440.0%+0.35%
28
New
18,827$142,7090.0%-23.22%
34
Increased
18,723(+25.4%)$141,9210.0%+8.16%
19
Decreased
18,627(-48.4%)$141,1930.0%+9.19%
0
Increased
16,384(+3965.5%)$124,1910.0%-23.08%
24

Showing 1-20 of 42

1 / 3
CVCVCAPSOVISION INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used